Editorial GuideCancer

Focus Issue: From Genomic Mutations to Oncogenic Pathways

See allHide authors and affiliations

Science Signaling  26 Mar 2013:
Vol. 6, Issue 268, pp. eg3
DOI: 10.1126/scisignal.2004149

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

This two-issue series focuses on how understanding how signaling pathways are altered in cancer cells can enable researchers to develop more effective therapies. Cancer is a pleiotropic disease. Tumor cells change over time and, even within a specific tumor, cells may have different mutations and dependencies on different signaling pathways for survival or for metastatic potential. New tools and technologies for genomic- or systems-level analysis, as well as conventional biochemistry and cell biology approaches, are revealing how signaling pathways contribute to cancer development, cancer evolution, and drug resistance.

View Full Text

Stay Connected to Science Signaling